Manulife (Manufacturers Life Insurance)’s Constellation Pharmaceuticals, Inc. CNST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-20,965
Closed -$709K 3310
2021
Q2
$709K Buy
20,965
+2,945
+16% +$75K ﹤0.01% 2192
2021
Q1
$421K Sell
18,020
-780
-4% -$23.6K ﹤0.01% 2404
2020
Q4
$541K Buy
18,800
+951
+5% +$23.9K ﹤0.01% 2154
2020
Q3
$362K Buy
17,849
+1,418
+9% +$34.6K ﹤0.01% 2166
2020
Q2
$470K Buy
16,431
+4,619
+39% +$166K ﹤0.01% 1999
2020
Q1
$371K Buy
11,812
+1,978
+20% +$68.8K ﹤0.01% 1976
2019
Q4
$463K Sell
9,834
-1,353
-12% -$39.1K ﹤0.01% 2092
2019
Q3
$72K Buy
11,187
+929
+9% +$7.76K ﹤0.01% 2871
2019
Q2
$126K Buy
+10,258
New +$114K ﹤0.01% 2839

Manulife (Manufacturers Life Insurance)'s CNST Position: Q3 2021 in Review

Manulife (Manufacturers Life Insurance) sold out of Constellation Pharmaceuticals, Inc. (CNST) in Q3 2021, closing a stake of 20,965 shares — an estimated $709K sold.

Manulife (Manufacturers Life Insurance) first reported a position in CNST in Q2 2019 and held it in 9 quarters. The position peaked at $709K in Q2 2021. 0 funds tracked by Wall St. Rank hold CNST as of Q3 2021.

  • Manulife (Manufacturers Life Insurance) reported no remaining Constellation Pharmaceuticals, Inc. position as of Q3 2021 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 20,965 Constellation Pharmaceuticals, Inc. shares in Q3 2021, an estimated $709K.
  • Manulife (Manufacturers Life Insurance) first reported a position in Constellation Pharmaceuticals, Inc. in Q2 2019 and held it in 9 quarters.
  • Manulife (Manufacturers Life Insurance)'s Constellation Pharmaceuticals, Inc. position peaked at $709K in Q2 2021.
  • 0 funds tracked by Wall St. Rank held Constellation Pharmaceuticals, Inc. as of Q3 2021.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q3 2021, filed 12 Nov 2021.